Scarica l'app Stockscreener
190.10
0.05%
0.10
Dopo l'orario di chiusura:
190.08
-0.02
-0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$190.00
Aprire:
$187.22
Volume 24 ore:
4.19M
Relative Volume:
1.09
Capitalizzazione di mercato:
$134.43B
Reddito:
$24.57B
Utile/perdita netta:
$3.60B
Rapporto P/E:
37.64
EPS:
5.051
Flusso di cassa netto:
$5.26B
1 W Prestazione:
-2.62%
1M Prestazione:
-9.13%
6M Prestazione:
+2.25%
1 anno Prestazione:
-10.67%
Intervallo 1D:
$186.01
$191.50
Intervallo di 1 settimana:
$186.01
$194.13
Portata 52W:
$171.00
$242.80
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
190.10 | 134.36B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
490.29 | 177.61B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
570.21 | 46.06B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.20 | 31.66B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
301.92 | 29.61B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Danaher Corp. stock faces pressure amid life sciences slowdown and biotech funding crunch - AD HOC NEWS
Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference - Insider Monkey
Spotting Winners: Danaher (NYSE:DHR) And Research Tools & Consumables Stocks In Q4 - Yahoo! Finance Canada
Danaher Corporation (NYSE:DHR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Leica Biosystems Solidifies Leadership in Digital Pathology with Launch of Next-Generation Aperio GT Elite Scanner and Aperio iQC Software - PR Newswire
Danaher (DHR) withdraws guarantor class for 0.200% Senior Notes due 2026 - Stock Titan
Quarterly Recap: What is the next catalyst for Danaher CorporationWeekly Market Report & Technical Confirmation Alerts - baoquankhu1.vn
Cytiva and San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) launch collaboration to advance next-generation genomic medicine platforms - Ricerca Malattie Genetiche Rare
Biotech Stocks Worth WatchingMarch 22nd - MarketBeat
Danaher Corporation $DHR Shares Sold by Nordea Investment Management AB - MarketBeat
After 5 long years, is this S&P 500 stock finally ready to bounce back? - Yahoo Finance UK
Danaher Stock: EPS Is Accelerating Toward $9 and Analysts Set $265 Mean Target - TIKR.com
Covea Finance Acquires 46,700 Shares of Danaher Corporation $DHR - MarketBeat
Sandhill Capital Partners LLC's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corp (NY: DHR - The Chronicle-Journal
Danaher will post Q1 results at 6 a.m. before April 21 call - Stock Titan
Is Danaher Corporation (DHR) A Good Stock To Buy Now? - Insider Monkey
Promising Biotech Stocks To Follow TodayMarch 20th - MarketBeat
Danaher Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Union Bancaire Privee UBP SA Has $13.93 Million Stake in Danaher Corporation $DHR - MarketBeat
Swiss Life Asset Management Ltd Has $20.41 Million Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Park National Corp OH - MarketBeat
Coastline Trust Co Acquires 5,312 Shares of Danaher Corporation $DHR - MarketBeat
CIBC Bancorp USA Inc. Makes New Investment in Danaher Corporation $DHR - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher (DHR) Jumps on Improved Q3 Earnings - MSN
Danaher Corporation $DHR Shares Bought by Mirova - MarketBeat
AIA Group Ltd Trims Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher to buy Masimo (MASI) for $180 a share; $305M breakup fee - Stock Titan
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher's Focus on Continuous Improvement Sets It Apart From Other Roll-Up Strategies - Morningstar
Movement Recap: Will Danaher Corporation outperform tech stocksMarket Performance Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Wilmington Savings Fund Society FSB Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danske Bank A S Acquires Shares of 371,722 Danaher Corporation $DHR - MarketBeat
CIBC Private Wealth Group LLC Has $402.41 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danica Pension Livsforsikringsaktieselskab Takes Position in Danaher Corporation $DHR - MarketBeat
DHR Forecast, Price Target & Analyst Ratings | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Abcam celebrates the Significant Individual Impact Award for Dr. Will Howat at the 2026 CiteAb Awards, alongside two product recognitions - Abcam
Maxi Investments CY Ltd Invests $3.25 Million in Danaher Corporation $DHR - MarketBeat
Focus Partners Wealth Purchases 42,286 Shares of Danaher Corporation $DHR - MarketBeat
12,215 Shares in Danaher Corporation $DHR Acquired by Cinctive Capital Management LP - MarketBeat
Danaher Corporation $DHR Holdings Cut by Alliancebernstein L.P. - MarketBeat
Danaher to acquire Irvine-based Masimo - Irvine Standard
Danaher Leaders Sued Over Waning Call for Virus Tests, Supplies - Bloomberg Law News
Destination Wealth Management Has $37.75 Million Holdings in Danaher Corporation $DHR - MarketBeat
Clark Capital Management Group Inc. Has $44.72 Million Holdings in Danaher Corporation $DHR - MarketBeat
Bamco Inc. NY Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Bank of Nova Scotia Sells 248,580 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.55%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):